Summary
The innate immune system senses pathogens largely through signals initiated by a collection of phylogenetically related proteins known as “Toll-like receptors” (TLRs), of which ten representatives are encoded in the human genome. The sensing role of the TLRs first came to light when one member of this family, TLR4, was shown to serve the detection of endotoxin (lipopolysaccharide; LPS) in mice. This discovery was based upon positional cloning of a spontaneous mutation affecting a locus known as Lps. The recognition specificities of other TLRs have since been established by reverse genetic methods. The understanding of the biochemical circuitry that maintains the innate capacity for immune recognition and response has loomed as the next hurdle in the field. A total of five adapter proteins with cytoplasmic domain homology to the TLRs are known to exist in mammals. These proteins are not entirely promiscuous in their interaction with TLRs, but rather, show preferential association with individual family members, giving a particular character to the signals that distinct micro-organisms initiate. The adaptive immune response is dependent upon upregulation of costimulatory molecules (UCM) such as CD80 and CD86. Very recently, it has been shown that this upregulation is dependent upon an adapter encoded by a locus known as Lps2, known as Trif or Ticam-1, and upon type I interferon receptor signaling. LPS and dsRNA both signal via Trif, but dsRNA has an accessory pathway for UCM, that is independent of both Trif/Ticam-1 and the known dsRNA receptor, TLR3. Other key innate immunity genes have also been disclosed by germline mutagenesis, and are discussed in the present review.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
11. References
G. Heppner and D. W. Weiss, High susceptibility of strain A mice to endotoxin and endotoxin-red blood cell mixtures, J. Bacteriol. 90:696–703 (1965).
J. M. Chiller, B. J. Skidmore, D. C. Morrison, and W. O. Weigle, Relationship of the structure of bacterial lipopolysaccharides to its function in mitogenesis and adjuvanticity, Proc. Natl. Acad. Sci. U. S. A 70(7), 2129–2133 (1973).
B. J. Skidmore, J. M. Chiller, D. C. Morrison, and W. O. Weigle, Immunologic properties of bacterial lipopolysaccharide (LPS): correlation between the mitogenic, adjuvant, and immunogenic activities, J. Immunol. 114(2 pt 2), 770–775 (1975).
B. J. Skidmore, D. C. Morrison, J. M. Chiller, and W. O. Weigle, Immunologic properties of bacterial lipopolysaccharide (LPS). II. The unresponsiveness of C3H/HeJ Mouse spleen cells to LPS-induced mitogenesis is dependent on the method used to extract LPS, J. Exp. Med. 142(6), 1488–1508 (1975).
B. J. Skidmore, J. M. Chiller, W. O. Weigle, R. Riblet, and J. Watson, Immunologic properties of bacterial lipopolysaccharide (LPS). III. Genetic linkage between the in vitro mitogenic and in vivo adjuvant properties of LPS, J. Exp. Med. 143(1), 143–150 (1976).
B. J. Skidmore, J. M. Chiller, and W. O. Weigle, Immunologic properties of bacterial lipopolysaccharide (LPS). IV. Cellular basis of the unresponsiveness of C3H/HeJ mouse spleen cells to LPS-induced mitogenesis, J. Immunol. 118(1), 274–281 (1977).
J. Watson and R. Riblet, Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic respones to lipopolysaccharides, J. Exp. Med. 140(5), 1147–1161 (1974).
S. M. Michalek, R. N. Moore, J. R. McGhee, D. L. Rosenstreich, and S. E. Mergenhagen, The primary role of lymphoreticular cells in the mediation of bost responses to bacterial endotoxin, J. Infec. Dis. 141:55–63 (1980).
A. D. O’Brien, D. L. Rosenstreich, and B. A. Taylor, Control of natural resistance to Salmonella typhimurium and Leishmania donovani in mice by closely linked but distinct genetic loci, Nature 287(5781), 440–442 (1980).
A. D. O’Brien, D. L. Rosentreich, I. Scher, G. H. Campbell, R. P. MacDermott, and S. B. Formal, Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene, J. Immunol. 124:20–24 (1980).
D. L. Rosenstreich, A. C. Weinblatt, and A. D. O’Brien, Genetic control of resistance to infection in mice, CRC Crit. Rev. Immunol. 3:263–330 (1982).
L. Hagberg, R. Hull, S. Hull, J. R. McGhee, S. M. Michalek, and C. Svanborg Eden, Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice, Infect. Immun. 46(3), 839–844 (1984).
A. Poltorak, I. Smirnova, X. L. He, M. Y. Liu, C. Van Huffel, O. McNally, D. Birdwell, E. Alejos, M. Silva, X. Du, P. Thompson, E. K. L. Chan, J. Ledesma, B. Roe, S. Clifton, S. N. Vogel, and B. Beutler, Genetic and physical mapping of the Lps locus-identification of the toll-4 receptor as a candidate gene in the critical region, Blood Cells Molecules & Diseases 24(17), 340–355 (1998).
A. Poltorak, X. He, I. Smimova, M.-Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. A. Freudenberg, P. Ricciardi-Castagnoli, B. Layton, and B. Beutler, Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene, Science 282(5396), 2085–2088 (1998).
B. Lemaitre, E. Nicolas, L. Michaut, J. M. Reichhart, and J. A. Hoffmann, The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults, Cell 86(6), 973–983 (1996).
S. Rutschmann, A. Kiline, and D. Ferrandon, Cutting edge: the toll pathway is required for resistance to gram-positive bacterial infections in Drosophila, J. Immunol. 168(4), 1542–1546 (2002).
N. Nomura, N. Miyajima, T. Sazuka, A. Tanaka, Y. Kawarabayasi, S. Sato, T. Nagase, N. Seki, K. Ishikawa, and S. Tabata, Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1, DNA Res. 1(1), 27–35 (1994).
T. Taguchi, J. L. Mitcham, S. K. Dower, J. E. Sims, and J. R. Testa, Chromosomal localization of TIL, a gene encoding a protein related to the Drosophila transmembrane receptor Toll, to human chromosome 4p14, Genom. 32(3), 486–488 (1996).
O. Takeuchi, K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira, Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components, Immunity 11(4), 443–451 (1999).
B. N. Gantner, R. M. Simmons, S. J. Canavera, S. Akira, and D. M. Underhill, Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2, J. Exp. Med. 197(9), 1107–1117 (2003).
L. Alexopoulou, A. C. Holt, R. Medzhitov, and R. A. Flavell, Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3, Nature 413(6857), 732–738 (2001).
F. Hayashi, K. D. Smith, A. Ozinsky, T. R. Hawn, E. C. Yi, D. R. Goodlett, J. K. Eng, S. Akira, D. M. Underhill, and A. Aderem, The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5, Nature 410(6832), 1099–1103 (2001).
H. Hemmi, O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira, A Toll-like receptor recognizes bacterial DNA, Nature 408(6813), 740–745 (2000).
H. Hemmi, T. Kaisho, O. Takeuchi, S. Sato, H. Sanjo, K. Hoshino, T. Horiuchi, H. Tomizawa, K. Takeda, and S. Akira, Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway, Nat. Immunol. 3(2), 196–200 (2002).
K. Tabcta et al., TLR9 and TLR3 as essential components of innate immune defense against mouse cytomegalovirus, Proc. Natl.Acad.Sci U.S.A. In Press. 2004.
N. J. Gay and F. J. Keith, Drosophila Toll and IL-1 receptor, Nature 351(6325), 355–356 (1991).
K. A. Lord, B. Hoffman-Liebermann, and D. A. Liebermann, Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6, Oncogene 5(7), 1095–1097 (1990).
D. Hultmark, Macrophage differentiation marker MyD88 is a member of the Toll/IL-1 receptor family, Biochem. Biophys. Res. Commun. 199(1), 144–146 (1994).
O. Adachi, T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira, Targeted disruption of the MyD88 gene results in loss of IL-1-and IL-18-mediated function, Immunity 9(1), 143–150 (1998).
T. Kawai, O. Adachi, T. Ogawa, K. Takeda, and S. Akira, Unresponsiveness of MyD88-deficient mice to endotoxin, Immunity 11(1), 115–122 (1999).
K. A. Fitzgerald, E. M. Palsson-McDermott, A. G. Bowie, C. A. Jefferies, A. S. Mansell, G. Brady, E. Brint, A. Dunne, P. Gray, M. T. Harte, D. McMurray, D. E. Smith, J. E. Sims, T. A. Bird, and L. A. O’Neill, Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction, Nature 413(6851), 78–83 (2001).
T. Horng, G. M. Barton, and R. Medzhitov, TIRAP: an adapter molecule in the Toll signaling pathway, Nat. Immunol. 2(9), 835–841 (2001).
H. Oshiumi, M. Matsumoto, K. Funami, T. Akazawa, and T. Seya, TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction, Nat. Immunol. 4:161–171 (2003).
M. Yamamoto, S. Sato, H. Hemmi, H. Sanjo, S. Uematsu, T. Kaisho, K. Hoshino, O. Takeuchi, M. Kobayashi, T. Fujita, K. Takeda, and S. Akira, Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4, Nature 420(6913), 324–329 (2002).
K. Hoebe, X. Du, J. Goode, N. Mann, and B. Beutler, Lps2: a new locus required for responses to lipopolysaccharide, revealed by germline mutagenesis and phenotypic screening, J. Endotoxin Res. 9(4), 250–255 (2003).
K. Hoebe, X. Du, P. Georgel, E. Janssen, K. Tabeta, S. O. Kim, J. Goode, P. Lin, N. Mann, S. Mudd, K. Crozat, S. Sovath, J. Han, and B. Beutler, Identifieation of Lps2 as a key transducer of MyD88-independent TIR signaling, Nature 424(6950), 743–748 (2003).
M. Yamamoto, S. Sato, K. Mori, K. Hoshino, O. Takeuchi, K. Takeda, and S. Akira, Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling, J. Immunol. 169(12), 6668–6672 (2002).
M. Yamamoto, S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Sanjo, O. Takeuchi, M. Sugiyama, M. Okabe, K. Takeda, and S. Akira, Role of adapter TRIF in the MyD88-independent Toll-like receptor signaling pathway, Science 301(5633), 640–643 (2003).
M. Yamamoto, S. Sato, H. Hemmi, S. Uematsu, K. Hoshino, T. Kaisho, O. Takeuchi, K. Takeda, and S. Akira, TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway, Nat. Immunol. 4(11), 1144–1150 (2003).
P. A. Lewis and D. Loomis, The formation of anti-sheep hemolytic amboceptor in the normal and tuberculous guinea pig, J. Exp. Med. 40:503 (1924).
R. M. Condie, S. J. Zak, and R. A. Good, Effect of Meningococcal Endotoxin on the Immune Response, Proceedings of the Society for Experimental Biology and Medicine 90(2), 355–360 (1955.
R. Medzhitov, P. Preston-Hurlburt, and C. A. Janeway, Jr., A human homologue of the Drosophila Toll protein signals activation of adaptive immunity, Nature 388(6640), 394–397 (1997).
T. Kaisho, O. Takeuchi, T. Kawai, K. Hoshino, and S. Akira, Endotoxin-induced maturation of myd88-deficient dendritic cells, J. Immunol. 166(9), 5688–5694 (2001).
T. Kaisho and S. Akira, Dendritic-cell function in Toll-like receptor-and MyD88-knockout mice, Trends Immunol. 22(2), 78–83 (2001).
K. Hoebe, E. M. Jannsen, S. O. Kim, L. Alexopoulou, R. A. Flavell, J. Han, and B. Beutler, Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways, Nature Immunology 4(12), 1223–1229 (2003).
Z. Jiang, M. Zamanian-Daryoush, H. Nie, A. M. Silva, B. R. Williams, and X. Li, Poly(dI.dC)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR, J. Biol. Chem. 278(19), 16713–16719 (2003).
M. G. Brown, A. O. Dokun, J. W. Heusel, H. R. Smith, D. L. Beckman, E. A. Blattenberger, C. E. Dubbelde, L. R. Stone, A. A. Scalzo, and W. M. Yokoyama, Vital involvement of a natural killer cell activation receptor in resistance to viral infection, Science 292(5518), 934–937 (2001).
H. R. Smith, J. W. Heusel, I. K. Mchta, S. Kim, B. G. Dorner, O. V. Naidenko, K. Iizuka, H. Furukawa, D. L. Beckman, J. T. Pingel, A. A. Scalzo, D. H. Fremont, and W. M. Yokoyama, Recognition of a virus-encoded ligand by a natural killer cell activation receptor, Proc. Natl. Acad. Sci. USA 99(13), 8826–8831 (2002).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science + Business Media, Inc.
About this paper
Cite this paper
Beutler, B., Hoebe, K., Georgel, P., Tabeta, K., Du, X. (2005). Genetic Analysis of Innate Immunity: Identification and Function of the TIR Adapter Proteins. In: Gupta, S., Paul, W.E., Steinman, R. (eds) Mechanisms of Lymphocyte Activation and Immune Regulation X. Advances in Experimental Medicine and Biology, vol 560. Springer, Boston, MA. https://doi.org/10.1007/0-387-24180-9_4
Download citation
DOI: https://doi.org/10.1007/0-387-24180-9_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-24188-3
Online ISBN: 978-0-387-24180-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)